Pathstone Family Office’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $900 | Hold |
|
|||||
|
2023
Q2 | $924 | Hold |
|
|||||
|
2023
Q1 | $2.61K | Sell |
|
|||||
|
2022
Q4 | $70.6K | Sell |
|
|||||
|
2022
Q3 | $5.54K | Buy |
|
|||||
|
2022
Q2 | $7.24K | Hold |
|
|||||
|
2022
Q1 | $8K | Hold |
|
|||||
|
2021
Q4 | $10K | Hold |
|
|||||
|
2021
Q3 | $17K | Hold |
|
|||||
|
2021
Q2 | $18K | Hold |
|
|||||
|
2021
Q1 | $20K | Hold |
|
|||||
|
2020
Q4 | $22K | Hold |
|
|||||
|
2020
Q3 | $28K | Hold |
|
|||||
|
2020
Q2 | $39K | Hold |
|
|||||
|
2020
Q1 | $8K | Hold |
|
|||||
|
2019
Q4 | $127K | Buy |
|
|||||
|
2019
Q3 | $5K | Hold |
|
|||||
|
2019
Q2 | $5K | Hold |
|
|||||
|
2019
Q1 | $21K | Buy |
|